MlynashMLansbergMGDe SilvaDA. Refining the definition of the malignant profile: Insights from the DEFUSE-EPITHET pooled data set. Stroke2011; 42: 1270–5.
2.
InoueMMlynashMStrakaM. Patients with the malignant profile within 3 h of symptom onset have very poor outcomes after intravenous tissue-type plasminogen activator therapy. Stroke2012; 43: 2494–6.